Singapore markets closed

Spruce Biosciences, Inc. (SPRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.5798+0.0049 (+0.85%)
At close: 04:00PM EDT
0.5820 +0.00 (+0.38%)
After hours: 05:32PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 23.66M
Enterprise value -53.34M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.32
Price/book (mrq)0.36
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.23

Trading information

Stock price history

Beta (5Y monthly) 2.42
52-week change 3-73.13%
S&P500 52-week change 323.28%
52-week high 35.9500
52-week low 30.5030
50-day moving average 30.6730
200-day moving average 31.8146

Share statistics

Avg vol (3-month) 3507.6k
Avg vol (10-day) 3393.67k
Shares outstanding 541.15M
Implied shares outstanding 641.15M
Float 824.75M
% held by insiders 17.75%
% held by institutions 150.94%
Shares short (28 Jun 2024) 4248.13k
Short ratio (28 Jun 2024) 40.43
Short % of float (28 Jun 2024) 40.64%
Short % of shares outstanding (28 Jun 2024) 40.60%
Shares short (prior month 31 May 2024) 440.29k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-631.02%

Management effectiveness

Return on assets (ttm)-28.36%
Return on equity (ttm)-53.55%

Income statement

Revenue (ttm)10.13M
Revenue per share (ttm)0.25
Quarterly revenue growth (yoy)1.90%
Gross profit (ttm)N/A
EBITDA -51.36M
Net income avi to common (ttm)-46.75M
Diluted EPS (ttm)-1.1200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)81.15M
Total cash per share (mrq)1.97
Total debt (mrq)4.15M
Total debt/equity (mrq)6.23%
Current ratio (mrq)4.67
Book value per share (mrq)1.62

Cash flow statement

Operating cash flow (ttm)-36.44M
Levered free cash flow (ttm)-17.93M